Tuesday, July 12, 2022

Sanofi Has One Hemophilia Winner On It Hands – But Fitusiran's Fate Remains Unclear

This not only outperforms older Factor VIII (FVIII) replacement products, but also the mean ABR rates achieved by BioMarin's late-stage gene therapy ...

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...